Search results
Forbes Daily: Look Out New York, Texas Could Get Its Own Stock Exchange
Forbes· 2 days agoThe etiquette around tipping has been upended by Covid-19, and more than a third of Americans think...
GSK Stock Dips on Delaware Court Ruling for Zantac Litigation
Zacks· 5 days agoFree Report) issued a statement disagreeing with the ruling by a state court in Delaware to allow jury trials for cases, which claim GSK’s discontinued heartburn drug Zantac (ranitidine) causes ...
Halozyme's (HALO) ENHANZE Product Gets New Patent Grant in EU
Zacks via Yahoo Finance· 2 days agoHalozyme (HALO) is set to benefit from the new patent grant in the EU, ensuring the protection of...
Costco membership-fee update prompts analysts to reset stock outlook
TheStreet.com· 4 days agoHere's what could happen next at Costco. Gary Millerchip wanted to set the record straight. Millerchip made his debut last week as Costco's (COST) new chief financial officer after former CFO ...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 5 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside...
Time in the Market Matters. Until It Doesn't.
TheStreet.com· 3 days agoNever confuse genius for a bull market. As a result, the argument that timing the market is far less important than time in the market has always held. Many market participants behave as if ...
Alphabet, Ventas, ASML And A Pharmaceutical Giant On CNBC’s ‘Final Trades’ - Alphabet (NASDAQ:GOOGL)
Benzinga· 3 days agoAlphabet recently declared a $2 billion investment plan to establish its inaugural data center and...
Forbes Daily: Warren Buffett’s Fortune Drops As Berkshire Stock Slumps
Forbes· 3 days agoMany of us spend our working years with the goal of retiring, but there are a number of reasons why...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks· 1 day agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.